Atractyloside

CAS : 17754-44-8

Ref. 3D-SAA75444

Informations sur le produit

• Nom: Atractyloside
• Synonymes: (2b,4a,15a)-15-Hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-b-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic Acid Dipotassium Salt, Atractylin (C30 glucoside), 1H-2,10a-Ethanophenanthrene, 19-norkaur-16-en-18-oic acid deriv., 17754-44-8, Potassium atractylate, 19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, potassium salt (1:2), (2β,4α,15α)-, 19-Norkaur-16-en-18-oic acid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-β-D-glucopyranosyl]oxy]-, dipotassium salt, (2β,4α,15α)-

Description

Atractyloside is a potent inhibitor of mitochondrial ADP/ATP translocase that is widely used in research to study the role of this protein in cellular energy metabolism. It has been shown to inhibit oxytocin-induced contractions of rat myometrium, and also exhibits anticancer properties. Atractyloside has been found to be an effective inhibitor of caffeine-induced DNA synthesis in Chinese hamster ovary cells, suggesting that it may have potential as a cancer therapy. Additionally, it has been shown to inhibit protein kinase activity and induce apoptosis in cancer cells, making it a promising candidate for the development of novel anticancer inhibitors. Overall, Atractyloside shows great potential as a powerful tool for research into the mechanisms underlying tumor growth and development.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 803 g/mol
• Formule: C₃₀H₄₄K₂O₁₆S₂
• Degré de pureté: Min. 95%